Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials.
Moyle
Graeme
G
Rajicic
Natasa
N
Goodrich
James
J
Mayer
Howard
H
Valdez
Hernan
H
D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes / Q000627:therapeutic use*; D004347:Drug Interactions; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D000077592:Maraviroc; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use*
D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014230:Triazoles; D000077592:Maraviroc